ClinicalTrials.Veeva

Menu

Trulimax (Azithromycin ) Non-Interventional Study In Acute Bacterial Upper Respiratory Tract Infections

Pfizer logo

Pfizer

Status

Completed

Conditions

Upper Respiratory Tract Infections

Study type

Observational

Funder types

Industry

Identifiers

NCT00827502
A0661198

Details and patient eligibility

About

To assess effectiveness of Trulimax (Azithromycin) in Acute Bacterial Upper Respiratory Tract Infections (URTIs).

Full description

Prospective, Open-label, Non-interventional and Multi-center Study NA

Enrollment

421 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Evidence of a personally signed and dated informed consent document indicating that the subject (or a legally acceptable representative) has been informed of all pertinent aspects of the study.
  • Patients with acute URTI, presumed to be of bacterial origin as per the clinical judgment of the investigator.

Exclusion criteria

N/A

Trial contacts and locations

11

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems